Atlas Trials

A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs

Clinical trial NCT06930625 · RECRUITING

Trial details

NCT number
NCT06930625
Sponsor
Debiopharm International SA
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Acromegaly
Start date
2025-11-26
Primary completion
2028-06-01
Enrollment
119

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.